HIV/AIDS
Description:
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source:
Physician Clinical Support System (PCSS) 0
Your rating: None
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
Information from the CDC on prevention, detection, and epidemiology of HIV/AIDS, including fact sheets suitable for patients.
Source:
Centers for Disease Control and Prevention (CDC) 0
Your rating: None
Tags:
Description:
This report by NIDA discusses the HIV/AIDS epidemic and how treating drug abuse is effective in preventing HIV.
Source:
National Institute on Drug Abuse (NIDA) 4.5
Your rating: None Average: 4.5 (4 votes)
Tags:
Description:
This survey of 375 physicians found that confidence addressing drug problems was positively associated with having a buprenorphine waiver.
Source:
Journal of General Internal Medicine, 2007 4.6
Your rating: None Average: 4.6 (5 votes)
Description:
This website, funded by SAMHSA, is designed to help physicians to implement office-based buprenorphine treatment using a national network of trained physician mentors.
Source:
Physician Clinical Support System (PCSS) 5
Your rating: None Average: 5 (2 votes)
Tags:
- General information - buprenorphine
- Getting a waiver/setting up your practice
- Logistics of buprenorphine treatment
- Addiction
- Behavioral therapy
- Billing
- Complicated patients
- Contraindications
- CPT
- Diversion
- Dosing
- Drug interactions
- HCPCSs
- Hepatitis
- HIV/AIDS
- Induction
- Methadone
- Pain
- Pregnant
- Psychiatric
- Psychosocial
- Special populations
- Suboxone
- Just became waivered
- Setting up a practice
Description:
This report describes points of intersection between HIV and primary care treatment, and discusses how to integrate HIV care into primary medicine.
Source:
The George Washington University School of Public Health and Health Services 4.8
Your rating: None Average: 4.8 (5 votes)
Tags:
Description:
This set of guidelines aids physicians in providing detoxification and substance abuse treatment, specifically examining co-occurring medical and psychiatric conditions.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.666665
Your rating: None Average: 4.7 (3 votes)
Description:
Guideline document discussing interactions between buprenorphine and HIV medication.
Source:
Physician Clinical Support System (PCSS) 4.75
Your rating: None Average: 4.8 (4 votes)
Tags:
Description:
This chapter of TIP 43 is aimed to help treatment providers identify co-occurring medical problems in patients who are addicted to opioids.
Source:
Substance Abuse and Mental Health Association (SAMHSA) 4.5
Your rating: None Average: 4.5 (4 votes)
Tags:
Description:
List of drugs that interact with buprenorphine due to their metabolism by Cytochrome P450.
Source:
Indiana University School of Medicine 4.5
Your rating: None Average: 4.5 (4 votes)
Tags:
- Home
- Training/CME
- Resources
- How-To Guides
- All How-To Guides
- Get Started Prescribing Buprenorphine
- Assess and Treat Patients with Comorbid Health Issues
- Conduct Buprenorphine Induction
- Establish and Manage a Buprenorphine Practice
- Manage Challenging Patients
- Comply with Rules, Regulations, and Recordkeeping
- Understand Insurance and Billing Issues
- Screen for Substance Abuse
- Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
- Your Bup Site!
- Site Blog